ENTITY

Halozyme Therapeutics (HALO US)

28
Analysis
Health Care • United States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
•11 Jul 2022 09:19•Syndicated

Weekly Stock Bullfinder - Week of 7/11

The war in Ukraine has thrown Europe into a full blown energy crisis that has resulted in a cost of living crisis for many EU countries as food and...

Share
x